Table 2 Clinical information on the patients.

From: Combination of urinary free-glycan markers for the diagnosis of various malignant tumors

 

N

G

C

P

B

E

Sex

n

age

n

age

n

age

n

age

n

age

n

age

M

61

65.1

81

68.2

39

64.1

32

62.8

8

75.5

36

68.9

F

59

63.7

59

60.2

48

61.0

23

65.3

5

68.6

9

54.4

total

120

64.4

140

64.8

87

62.4

55

63.8

13

72.8

45

66.0

 

L

H

Ov

En

Ce

Sa

Sex

n

age

n

age

n

age

n

age

n

age

n

age

M

21

68.4

21

63.0

      

36

61.7

F

8

65.0

10

67.5

12

55.3

13

62.0

9

52.8

33

64.5

total

29

67.5

31

64.5

      

69

63.1

  1. N, normal control; G, gastric cancer; C, colorectal cancer; P, pancreatic cancer; B, bile duct cancer; E, esophagus cancer; L, lung cancer; H, hematological tumor; Ov, ovarian cancer; En, endometrial cancer; Ce, cervical cancer; Sa, sarcoma. M and F refer to male and female, respectively.
Back to article page